Sign in
4

Changes in Ownership

BeOne Medicines Ltd. Filed Acc 0001628280-25-040535

SVP, General Counsel sold 11,013 shares at an average $300.45 ($3,308,877)

  • SVP, General Counsel acquired 8,230 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lee Chan Henry SVP, General Counsel 2025-08-13 Sale 10b5-1 −1,112 $300.00 $333,600 0 D: show line 1 in the form
Lee Chan Henry SVP, General Counsel 2025-08-13 Option exercise 10b5-1 +4,381 $194.47 $851,973 4,381 D: show line 2 in the form
Lee Chan Henry SVP, General Counsel 2025-08-13 Option exercise 10b5-1 +3,849 $159.03 $612,106 8,230 D: show line 3 in the form
Lee Chan Henry SVP, General Counsel 2025-08-13 Sale 10b5-1 −6,052 $300.19 $1,816,724 2,178 D: show line 4 in the form
Lee Chan Henry SVP, General Counsel 2025-08-13 Sale 10b5-1 −3,849 $301.00 $1,158,553 0 D: show line 5 in the form
Open-market sales · 11,013 sh · avg $300.45 · $3,308,877

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lee Chan Henry SVP, General Counsel 2025-08-13 Option exercise · Share Option (Right to Buy) 10b5-1 −56,953 131,976 D: show line 6 in the form
Lee Chan Henry SVP, General Counsel 2025-08-13 Option exercise · Share Option (Right to Buy) 10b5-1 −50,037 134,758 D: show line 7 in the form
Loading xslF345X05/wk-form4_1755290322.xml…